HQL
Price:
$16.95
Market Cap:
$515.42M
Tekla Life Sciences Investors, a closed-ended equity mutual fund, is expertly managed by Tekla Capital Management LLC. This U.S.-domiciled fund, which commenced operations on February 20, 1992, and was formerly known as H&Q Life Sciences Investors, seeks investment opportunities in publicly traded companies worldwide. Its primary focus lies within the broad life sciences sector, encompassing a diverse range of industries such as biotechnology, pharmaceuticals, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, and medical devices and supplies. The fund also extends its investment purview to include the agriculture and environmental ...[Read more]
Industry
Asset Management
IPO Date
1992-05-01
Stock Exchange
NYSE
Ticker
HQL
According to Tekla Life Sciences Investors’s latest financial reports and current stock price. The company's current PE Ratio is 2.55. This represents a change of 162.06% compared to the average of 0.97 of the last 4 quarters.
The mean historical PE Ratio of Tekla Life Sciences Investors over the last ten years is 3.27. The current 2.55 PE Ratio has changed 7.69% with respect to the historical average. Over the past ten years (40 quarters), HQL's PE Ratio was at its highest in in the September 2017 quarter at 1.37K. The PE Ratio was at its lowest in in the September 2023 quarter at -7.29.
Average
3.27
Median
5.10
Minimum
-18.73
Maximum
15.91
Discovering the peaks and valleys of Tekla Life Sciences Investors PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 137.72%
Maximum Annual PE Ratio = 15.91
Minimum Annual Increase = -171314.37%
Minimum Annual PE Ratio = -18.73
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 5.23 | 5.46% |
| 2024 | 4.96 | -68.57% |
| 2023 | 15.78 | -570.70% |
| 2022 | -3.35 | -142.89% |
| 2021 | 7.82 | 129.52% |
| 2020 | 3.41 | -168.60% |
| 2019 | -4.97 | -131.22% |
| 2018 | 15.91 | 137.72% |
| 2017 | 6.69 | -135.72% |
| 2016 | -18.73 | -171314.37% |
The current PE Ratio of Tekla Life Sciences Investors (HQL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.66
5-year avg
6.09
10-year avg
3.27
Tekla Life Sciences Investors’s PE Ratio is greater than CION Investment Corporation (-370.54), greater than BlackRock TCP Capital Corp. (-2.53), less than Gladstone Capital Corporation (9.97), less than GigCapital7 Corp. (476.03), greater than Eagle Point Credit Company Inc. (-4.06), less than PennantPark Investment Corporation (17.83), less than Source Capital, Inc. (8.38), less than Barings Corporate Investors (16.10), less than Crescent Capital BDC, Inc. (27.55), less than Gladstone Investment Corporation (3.14),
| Company | PE Ratio | Market cap |
|---|---|---|
| -370.54 | $347.53M | |
| -2.53 | $317.99M | |
| 9.97 | $438.08M | |
| 476.03 | $172.00M | |
| -4.06 | $505.04M | |
| 17.83 | $251.39M | |
| 8.38 | $372.45M | |
| 16.10 | $365.89M | |
| 27.55 | $414.89M | |
| 3.14 | $613.21M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tekla Life Sciences Investors using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tekla Life Sciences Investors or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Tekla Life Sciences Investors's PE Ratio?
How is the PE Ratio calculated for Tekla Life Sciences Investors (HQL)?
What is the highest PE Ratio for Tekla Life Sciences Investors (HQL)?
What is the 3-year average PE Ratio for Tekla Life Sciences Investors (HQL)?
What is the 5-year average PE Ratio for Tekla Life Sciences Investors (HQL)?
How does the current PE Ratio for Tekla Life Sciences Investors (HQL) compare to its historical average?